REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 439 filers reported holding REPLIGEN CORP in Q1 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $135,983,762 | +57.4% | 855,190 | +40.0% | 0.88% | +66.0% |
| Q2 2023 | $86,395,988 | -7.7% | 610,745 | +9.8% | 0.53% | -9.7% |
| Q1 2023 | $93,613,211 | +59.2% | 556,030 | +60.1% | 0.59% | +56.2% |
| Q4 2022 | $58,818,294 | +43.7% | 347,400 | +58.8% | 0.38% | +35.1% |
| Q3 2022 | $40,928,000 | – | 218,735 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |